Exploring Maintenance Therapy in Pediatric Embryonal Tumor With Multilayered Rosettes.

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Genetics

Background:

• Embryonal tumors with multilayered rosettes (ETMR) are rare, aggressive pediatric brain tumors.
• Historically, ETMR has had very poor survival rates, often less than 14% at 1 year.
• Recent studies show improved survival, but long-term outcomes remain a challenge.

Purpose of the Study:

• To report a case of ETMR in an infant.
• To evaluate the feasibility and safety of a novel maintenance therapy regimen.
• To assess the long-term outcome of a patient treated with this regimen.

Main Methods:

• Diagnosis of ETMR confirmed by chromosome 19 microRNA cluster amplification.
• Treatment included surgery, high-dose chemotherapy with stem cell rescue, and proton therapy.
• A 12-month maintenance regimen of intrathecal topotecan, oral sodium valproate, and oral cis-retinoic acid was administered.

Main Results:

• The patient achieved disease-free status after initial treatment.
• The maintenance therapy was well tolerated with manageable adverse effects.
• The patient remains progression-free for 32 months postmaintenance therapy (50 months from initial presentation).

Conclusions:

• This case demonstrates the feasibility and safety of a multi-agent maintenance therapy for ETMR.
• The observed long-term remission suggests this approach may improve outcomes for children with ETMR.
• Further research is warranted to establish the efficacy of this maintenance strategy.